Hvis der optræder grad 2 eller 3 hand- foot syndrome skal behandlingen med Xeloda afbrydes indtil symptomerne forsvinder eller er aftaget i intensitet til grad 1.
If grade 2 or 3 hand- foot syndrome occurs, administration of Xeloda should be interrupted until the event resolves or decreases in intensity to grade 1.